Merriman believes that data released this afternoon indicates that Oxigene's Zybrestat is generally safe when used in combination with Avastin and chemotherapy. The firm thinks that Oxigene's technology can be an effective tool in fighting cancer and it reiterates a Buy rating on the stock. :theflyonthewall.com
News For OXGN From The Last 14 Days
Check below for free stories on OXGN the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
